Xylem (NYSE:XYL) Stock Rating Cut to Hold at Argus

Xylem (NYSE:XYL) was downgraded by analysts at Argus from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday, MarketBeat Ratings reports.

Other equities research analysts also recently issued research reports about the stock. Zacks Research downgraded shares of Xylem from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 29th. Oppenheimer lowered their price target on shares of Xylem from $150.00 to $135.00 and set an “outperform” rating on the stock in a report on Wednesday, October 28th. BNP Paribas Exane dropped their price objective on shares of Xylem from $145.00 to $135.00 and set an “outperform” rating for the company in a research note on Wednesday, October 28th. JPMorgan Chase & Co. downgraded shares of Xylem from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $118.00 to $90.00 in a report on Wednesday, October 28th. Finally, The Goldman Sachs Group decreased their target price on shares of Xylem from $160.00 to $138.00 and set a “buy” rating on the stock in a research report on Wednesday, October 28th. Nine analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $121.31.

Xylem Price Performance

Shares of XYL stock opened at $96.08 on Wednesday. Xylem has a 12 month low of $87.40 and a 12 month high of $152.43. The company has a market capitalization of $22.04 billion, a P/E ratio of 21.26, a P/E/G ratio of 1.62 and a beta of 1.01. The stock has a 50 day moving average of $104.36 and a two-hundred day moving average of $117.13. The company has a current ratio of 1.39, a quick ratio of 1.02 and a debt-to-equity ratio of 0.23.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). The firm had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.28 billion. Xylem had a net margin of 11.94% and a return on equity of 12.06%. The business’s revenue for the quarter was down 3.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.37 earnings per share. As a group, equities analysts expect that Xylem will post 5.45 EPS for the current year.

Insider Activity at Xylem

In other news, Director D Koch bought 11,000 shares of Xylem stock in a transaction dated Thursday, October 29th. The shares were bought at an average price of $89.60 per share, for a total transaction of $985,600.00. Following the purchase, the director owned 12,247 shares of the company’s stock, valued at approximately $1,097,331.20. This trade represents a 882.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.32% of the company’s stock.

Hedge Funds Weigh In On Xylem

Several institutional investors have recently added to or reduced their stakes in the company. William Mack & Associates Inc. bought a new stake in Xylem during the third quarter worth about $25,000. Dunhill Financial LLC acquired a new stake in shares of Xylem during the second quarter worth approximately $30,000. Avalon Trust Co acquired a new stake in shares of Xylem during the second quarter worth approximately $35,000. Orion Capital Management LLC bought a new position in shares of Xylem in the second quarter valued at approximately $35,000. Finally, Aventus Investment Advisors Inc. raised its stake in shares of Xylem by 66.7% in the second quarter. Aventus Investment Advisors Inc. now owns 300 shares of the industrial products company’s stock valued at $35,000 after acquiring an additional 120 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.